Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort. Handy A, Banerjee A, Wood AM, Dale C, et al. Heart 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325.

Read + Share

Amedeo Smart

Independent Medical Education

Handy A, Banerjee A, Wood AM, Dale C, et al. Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort. Heart 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325.
PMID: 35273122